Advertisement
Advertisement

TNDM

TNDM logo

Tandem Diabetes Care, Inc.

16.72
USD
Sponsored
+1.90
+12.82%
May 28, 16:00 UTC -4
Closed
exchange

After-Market

16.95

+0.23
+1.41%

Tandem Diabetes Care, Inc. Profile

About

Tandem Diabetes Care, Inc. designs, develops and markets products for people with insulin-dependent diabetes. The company's flagship product, the t:slim X2 Insulin Delivery System, or t:slim X2, is based on its proprietary technology platform. Per the company, t:slim X2 is the smallest durable insulin pump available and is also the only available pump capable of remote feature updates.Tandem Diabetes also offers t:flex insulin delivery system which includes t:flex pump, its 480-unit disposable insulin cartridge, an infusion set, t:lock cartridge and infusion set products, various pump accessories along with t:slim X2 with G5 integration.

Info & Links

CEO

John F. Sheridan

Headquarters

12400 HIGH BLUFF DRIVE
San Diego, CA 92130, UNITED STATES

Industry

Medical Instruments

Sector

Medical

Website

www.tandemdiabetes.com

Auditor

Ernst & Young LLP

Share holders

38

Employees

2,500

Tandem Diabetes Care, Inc. Statistics

Valuation Measures

Market Capitalization2

1.16B

Enterprise Value

1.58B

Enterprise Value/EBITDA(ttm)

-23.49

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

1.33

Price to Book(mrq)

8.60

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

53.59%

Operating Margin(ttm)

-9.69%

Profit Margin(ttm)

-21.54%

Return on Equity(ttm)

-68.23%

Return on Invested Capital(ttm)

-44.89%

Return on Assets(ttm)

-11.07%

Income Statement

Revenue(ttm)

1.03B

Revenue Per Share(ttm)

14.99

Gross Profit(ttm)

564.40M

EBITDA(ttm)3

-67.45M

Net Income Available to Common(ttm)

-94.55M

Diluted EPS(ttm)

-3.07

Share Statistics

Beta (5Y Monthly)

1.74

52-Week Change

-22.16%

S&P 500 52-Week Change

28.45%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

68.53M

Dividend Yield

0.00%

Float4

67.20M

% Held by Insiders

1.90%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

570.26M

Total Cash Per Share(mrq)

8.32

Total Debt(mrq)

601.77M

Total Debt/Equity(mrq)

199.80%

Current Ratio(mrq)

2.55%

Quick Ratio(mrq)

2.02%

Book Value Per Share(mrq)

2.27

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.14

Free Cash Flow(ytd)

-29.67M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement